Physician

Christiane Kelly Hunt, DO

According to 2025 Medicare claims, Christiane Hunt, DO (NPI: 1144483561) practices ophthalmology in the Columbus, OH market, with the plurality of this provider's patient population coming from Franklin, OH. This provider's primary affiliated billing organization is RETINA GROUP, INC (NPI: 1588794200; TIN: 311460051) and primary practice location at 43701-1487.

Hunt's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 749 traditional Medicare patients, billed 21,828 HCPCS/CPT codes, and received $2,670,367 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 495 prescription claims across 189 beneficiaries totaling $12,648 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 52 records totaling $1,373. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $421,024 to $2,670,367. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $62,128 to $12,648. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.7M2015 Medicare payment: $421,024 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $719,266 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,146,130 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,372,840 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,687,446 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,946,814 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,186,785 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,473,682 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,670,367 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157524,651$421,024
2016N/RN/RN/R
20176245,613$719,266
20187138,582$1,146,130
20197037,895$1,372,840
20208187,870$1,687,446
20218378,702$1,946,814
202278910,236$2,186,785
202376118,058$2,473,682
202474921,828$2,670,367

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$31K$62K2015 Drug cost: $62,128 (USD; Tot_Drug_Cst)2016 Drug cost: $22,534 (USD; Tot_Drug_Cst)2017 Drug cost: $11,359 (USD; Tot_Drug_Cst)2018 Drug cost: $14,391 (USD; Tot_Drug_Cst)2019 Drug cost: $15,673 (USD; Tot_Drug_Cst)2020 Drug cost: $25,272 (USD; Tot_Drug_Cst)2021 Drug cost: $24,594 (USD; Tot_Drug_Cst)2022 Drug cost: $21,357 (USD; Tot_Drug_Cst)2023 Drug cost: $14,647 (USD; Tot_Drug_Cst)2024 Drug cost: $12,648 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015158703$62,128
2016130373$22,534
2017120318$11,359
2018168435$14,391
2019150426$15,673
2020172496$25,272
2021182514$24,594
2022157471$21,357
2023165386$14,647
2024189495$12,648

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2052,022$656
67028Injection of drug into eye3471,559$89
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more338356$88
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more268397$62
92134Imaging of retina7111,642$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1765,192$4,964
Ketorolac TromethamineKetorolac Tromethamine461,698$1,049
Atropine SulfateAtropine Sulfate12725$611
Brimonidine TartrateBrimonidine Tartrate13869$520
OfloxacinOfloxacin531,129$465

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.52$1,373Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Christiane Kelly Hunt, DO?

Tedicare shows public-source Medicare data for Christiane Kelly Hunt, DO (NPI 1144483561), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christiane Kelly Hunt, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Christiane Kelly Hunt, DO?

Christiane Kelly Hunt, DO is linked to RETINA GROUP, INC (billing NPI 1588794200) in the available physician profile data.

Does Christiane Kelly Hunt, DO have Open Payments data?

Christiane Kelly Hunt, DO has 52 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.